Portfolio companies

Cinclus Pharma is a Swedish late-stage biopharmaceutical company committed to improving the medical outcome for patients suffering from severe stomach acid-related disorders. Cinclus Pharma’s lead candidate, Linaprazan glurate, holds the potential to decrease the unnecessary use of antibiotics, thereby reducing the development of antimicrobial resistance.

Identity (3)

MinervaX is a Danish biotech company developing a maternal vaccine to prevent life-threatening infections in newborns. The vaccine seeks to avoid Group B streptococcus (“GBS”) bacteria responsible for infant deaths, stillbirths and severe disabilities in children globally. 

MinervaX

tado° is a German green tech company enabling significant energy savings and CO2 reductions by providing smart home climate management controls and dynamic clean energy tariffs. The combined offering directly addresses the growing climate crisis and proliferating energy costs for households.

214306976-d3e43b45-5b73-499c-a57f-f2e1c5483dc3

This website uses cookiesfor statistics and user experience.

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.

Cookies